Saba Capital Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.89M | Buy |
1,260,129
+280,613
| +29% | +$867K | 0.09% | 104 |
|
|
2025
Q1 | $3.42M | Buy |
979,516
+91,523
| +10% | +$319K | 0.09% | 89 |
|
|
2024
Q4 | $2.9M | Buy |
887,993
+211,566
| +31% | +$692K | 0.07% | 101 |
|
|
2024
Q3 | $2.6M | Buy |
676,427
+25,000
| +4% | +$96.3K | 0.05% | 127 |
|
|
2024
Q2 | $2.01M | Buy |
651,427
+277,967
| +74% | +$859K | 0.03% | 133 |
|
|
2024
Q1 | $964K | Buy |
+373,460
| New | +$964K | 0.02% | 155 |
|